Vanguard Group Inc Opiant Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$9.38 - $20.29 $33,908 - $73,348	3,615 Added 1.93%	190,773 $3.87 Million
Q1 2022 May 13, 2022	BUY	$19.54 - $33.59 $169,978 - $292,199	8,699 Added 4.87%	187,158 $4.01 Million
Q4 2021 Feb 14, 2022	BUY	$22.51 - $36.79 $915,909 - $1.5 Million	40,689 Added 29.53%	178,459 $6 Million
Q3 2021 Nov 12, 2021	BUY	$13.28 - $25.79 $10,690 - $20,760	805 Added 0.59%	137,770 $3.55 Million
Q2 2021 Aug 13, 2021	BUY	$10.5 - $14.19 $1.44 Million - $1.94 Million	136,965 New	136,965 $1.83 Million

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.